Logo image of TOI

ONCOLOGY INSTITUTE INC/THE (TOI) Stock Earnings & Estimates

USA - Nasdaq - NASDAQ:TOI - US68236X1000 - Common Stock

3.03 USD
-0.2 (-6.19%)
Last: 12/5/2025, 8:00:01 PM
3.11 USD
+0.08 (+2.64%)
After Hours: 12/5/2025, 8:00:01 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027
Revenue
YoY % growth
TOI revenue by date.TOI revenue by date.
252.5M
24.38%
324.239M
28.41%
393.412M
21.33%
505.58M
28.51%
624.58M
23.54%
745.08M
19.29%
EBITDA
YoY % growth
TOI ebitda by date.TOI ebitda by date.
-67.59M
-58.81%
-54.278M
19.70%
-53.831M
0.82%
-11.982M
77.74%
2.643M
122.06%
23.634M
794.21%
EBIT
YoY % growth
TOI ebit by date.TOI ebit by date.
-72M
-56.86%
-60.151M
16.46%
-60.118M
0.05%
-34.159M
43.18%
-19.827M
41.96%
2.354M
111.87%
Operating Margin
TOI operating margin by date.TOI operating margin by date.
-28.51%-18.55%-15.28%-6.76%-3.17%0.32%
EPS
YoY % growth
TOI eps by date.TOI eps by date.
N/A-0.69
-36.63%
N/A
38.52%
-0.56
-32.54%
-0.26
53.89%
-0.10
61.04%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26
EPS
Q2Q % growth
-0.08
-9.53%
-0.08
55.44%
-0.07
52.87%
-0.05
63.93%
Revenue
Q2Q % growth
141.17M
40.79%
141.3M
35.33%
152.07M
26.93%
163.86M
19.99%
EBITDA
Q2Q % growth
828.2K
114.68%
-651.45K
91.98%
-202K
97.35%
-373.7K
86.37%
EBIT
Q2Q % growth
-4.683M
60.74%
-5.507M
44.44%
-5.205M
53.57%
-5.225M
35.13%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
-0.14
22.22%
-0.11-0.03-22.31%
Q2 2025
Q2Q % growth
-0.15
11.76%
-0.13-0.02-14.24%
Q1 2025
Q2Q % growth
-0.17
22.73%
%
Q4 2024
Q2Q % growth

66.33%
-0.07%
Q3 2024
Q2Q % growth
-0.18
5.26%
-0.06-0.12-197.03%
Q2 2024
Q2Q % growth
-0.17
10.53%
-0.10-0.07-68.32%
Q1 2024
Q2Q % growth
-0.22
-120.00%
-0.12-0.10-81.52%
Q4 2023
Q2Q % growth
-0.21
16.00%
-0.11-0.10-89.02%
Q3 2023
Q2Q % growth
-0.19
24.00%
-0.13-0.06-44.71%
Q2 2023
Q2Q % growth
-0.19 -0.17-0.02-10.66%
Q4 2022
Q2Q % growth
-0.25 -0.18-0.07-37.51%
Q3 2022
Q2Q % growth
-0.25 -0.18-0.07-37.51%
TOI Yearly EPS VS EstimatesTOI Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 -0.2 -0.4 -0.6
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
136.564M
36.70%
123.86M12.704M10.26%
Q2 2025
Q2Q % growth
119.802M
21.53%
115.75M4.052M3.50%
Q1 2025
Q2Q % growth
104.41M
10.29%
%
Q4 2024
Q2Q % growth
100.267M
16.88%
110.24M-9.973M-9.05%
Q3 2024
Q2Q % growth
99.9M
21.78%
108.62M-8.72M-8.03%
Q2 2024
Q2Q % growth
98.578M
22.88%
104.34M-5.762M-5.52%
Q1 2024
Q2Q % growth
94.666M
24.25%
96.117M-1.451M-1.51%
Q4 2023
Q2Q % growth
85.788M
20.12%
82.862M2.926M3.53%
Q3 2023
Q2Q % growth
82.035M
26.25%
75.411M6.624M8.78%
Q2 2023
Q2Q % growth
80.224M
31.69%
74.527M5.697M7.64%
Q1 2023
Q2Q % growth
76.19M
38.13%
%
Q4 2022
Q2Q % growth
71.42M
36.56%
65.398M6.022M9.21%
Q3 2022
Q2Q % growth
64.98M
24.32%
69.64M-4.66M-6.69%
Q2 2022
Q2Q % growth
60.92M
22.23%
%
Q1 2022
Q2Q % growth
55.16M
13.54%
%
Q4 2021
Q2Q % growth
52.3M
6.80%
%
Q3 2021
Q2Q % growth
52.27M
10.62%
%
TOI Yearly Revenue VS EstimatesTOI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS14.81% 45.24% -4.38% 7.22%
Revenue9.85% 9.28% 5.59% 5.37%